Cargando…

The acceptance and hesitancy of COVID-19 vaccination among chronic obstructive pulmonary disease (COPD) patients

Severe acute respiratory syndrome coronavirus 2, which is responsible for the coronavirus disease 2019 (COVID-19), causes severe clinical outcomes in old individuals and patients with underlying diseases, including chronic obstructive pulmonary disease (COPD). Considering vaccination is still the mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting, Bai, Yang, Bai, Lele, Wang, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312365/
https://www.ncbi.nlm.nih.gov/pubmed/37390289
http://dx.doi.org/10.1097/MD.0000000000033923
_version_ 1785066917448384512
author Wang, Ting
Bai, Yang
Bai, Lele
Wang, Ning
author_facet Wang, Ting
Bai, Yang
Bai, Lele
Wang, Ning
author_sort Wang, Ting
collection PubMed
description Severe acute respiratory syndrome coronavirus 2, which is responsible for the coronavirus disease 2019 (COVID-19), causes severe clinical outcomes in old individuals and patients with underlying diseases, including chronic obstructive pulmonary disease (COPD). Considering vaccination is still the most effective method to prevent COVID-19-associated death, it is imperative to evaluate COPD patients’ attitudes toward the COVID-19 vaccine. This cross-sectional design study was conducted to assess vaccine acceptance and hesitancy among 212 COPD patients who attended the outpatient department from January 1, 2021, to July 31, 2022. All of the patients were not vaccinated and had undertaken lung function test at the time of our survey. Of 212 participants, 164 (77.4%) were willing to be vaccinated immediately while 48 (22.6%) were hesitant to be vaccinated. Compared with the acceptance group, patients who did not accept the vaccination instantly tended to have more comorbidities, like hypertension, coronary heart disease, recent cancers, and higher Modified British Medical Research Council score, or more frequent acute exacerbation. For the patients willing to be vaccinated, the main factors motivating them were an authorities-endorsed vaccine, free vaccination, and no obvious adverse reactions. For the hesitant group, no recommendation from the treating physician was the biggest obstacle for them to accept vaccination. Our results provide useful guidance for making intervention measures to enhance COPD patients’ acceptance of a new COVID-19 vaccine. For those patients with comorbidities, treating physicians promoting messages framing the safety of vaccination is necessary to increase immunization rates.
format Online
Article
Text
id pubmed-10312365
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103123652023-07-01 The acceptance and hesitancy of COVID-19 vaccination among chronic obstructive pulmonary disease (COPD) patients Wang, Ting Bai, Yang Bai, Lele Wang, Ning Medicine (Baltimore) 6600 Severe acute respiratory syndrome coronavirus 2, which is responsible for the coronavirus disease 2019 (COVID-19), causes severe clinical outcomes in old individuals and patients with underlying diseases, including chronic obstructive pulmonary disease (COPD). Considering vaccination is still the most effective method to prevent COVID-19-associated death, it is imperative to evaluate COPD patients’ attitudes toward the COVID-19 vaccine. This cross-sectional design study was conducted to assess vaccine acceptance and hesitancy among 212 COPD patients who attended the outpatient department from January 1, 2021, to July 31, 2022. All of the patients were not vaccinated and had undertaken lung function test at the time of our survey. Of 212 participants, 164 (77.4%) were willing to be vaccinated immediately while 48 (22.6%) were hesitant to be vaccinated. Compared with the acceptance group, patients who did not accept the vaccination instantly tended to have more comorbidities, like hypertension, coronary heart disease, recent cancers, and higher Modified British Medical Research Council score, or more frequent acute exacerbation. For the patients willing to be vaccinated, the main factors motivating them were an authorities-endorsed vaccine, free vaccination, and no obvious adverse reactions. For the hesitant group, no recommendation from the treating physician was the biggest obstacle for them to accept vaccination. Our results provide useful guidance for making intervention measures to enhance COPD patients’ acceptance of a new COVID-19 vaccine. For those patients with comorbidities, treating physicians promoting messages framing the safety of vaccination is necessary to increase immunization rates. Lippincott Williams & Wilkins 2023-06-30 /pmc/articles/PMC10312365/ /pubmed/37390289 http://dx.doi.org/10.1097/MD.0000000000033923 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 6600
Wang, Ting
Bai, Yang
Bai, Lele
Wang, Ning
The acceptance and hesitancy of COVID-19 vaccination among chronic obstructive pulmonary disease (COPD) patients
title The acceptance and hesitancy of COVID-19 vaccination among chronic obstructive pulmonary disease (COPD) patients
title_full The acceptance and hesitancy of COVID-19 vaccination among chronic obstructive pulmonary disease (COPD) patients
title_fullStr The acceptance and hesitancy of COVID-19 vaccination among chronic obstructive pulmonary disease (COPD) patients
title_full_unstemmed The acceptance and hesitancy of COVID-19 vaccination among chronic obstructive pulmonary disease (COPD) patients
title_short The acceptance and hesitancy of COVID-19 vaccination among chronic obstructive pulmonary disease (COPD) patients
title_sort acceptance and hesitancy of covid-19 vaccination among chronic obstructive pulmonary disease (copd) patients
topic 6600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312365/
https://www.ncbi.nlm.nih.gov/pubmed/37390289
http://dx.doi.org/10.1097/MD.0000000000033923
work_keys_str_mv AT wangting theacceptanceandhesitancyofcovid19vaccinationamongchronicobstructivepulmonarydiseasecopdpatients
AT baiyang theacceptanceandhesitancyofcovid19vaccinationamongchronicobstructivepulmonarydiseasecopdpatients
AT bailele theacceptanceandhesitancyofcovid19vaccinationamongchronicobstructivepulmonarydiseasecopdpatients
AT wangning theacceptanceandhesitancyofcovid19vaccinationamongchronicobstructivepulmonarydiseasecopdpatients
AT wangting acceptanceandhesitancyofcovid19vaccinationamongchronicobstructivepulmonarydiseasecopdpatients
AT baiyang acceptanceandhesitancyofcovid19vaccinationamongchronicobstructivepulmonarydiseasecopdpatients
AT bailele acceptanceandhesitancyofcovid19vaccinationamongchronicobstructivepulmonarydiseasecopdpatients
AT wangning acceptanceandhesitancyofcovid19vaccinationamongchronicobstructivepulmonarydiseasecopdpatients